Avalo Therapeutics, Inc.Avalo Therapeutics, Inc.Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc.

No trades
See on Supercharts

Price target

33.000.000.00%
The 3 analysts offering 1 year price forecasts for AVTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to AVTX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AVTX EPS for the last quarter is −2.83 USD despite the estimation of −1.19 USD. In the next quarter EPS is expected to reach −1.42 USD. Track more of Avalo Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Avalo Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Avalo Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, AVTX price target is 33.00 USD with a max estimate of 40.00 USD and a min estimate of 24.00 USD. Check if this forecast comes true in a year, meanwhile watch Avalo Therapeutics, Inc. stock price chart and keep track of the current situation with AVTX news and stock market news.